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Abstract
The absence of the transcriptional repressor RE-1 Silencing Transcription Factor (REST) in insulin-secreting beta cells is a
major cue for the specific expression of a large number of genes. These REST target genes were largely ascribed to a
function of neurotransmission in a neuronal context, whereas their role in pancreatic beta cells has been poorly explored. To
identify their functional significance, we have generated transgenic mice expressing REST in beta cells (RIP-REST mice), and
previously discovered that REST target genes are essential to insulin exocytosis. Herein we characterized a novel line of RIP-
REST mice featuring diabetes. In diabetic RIP-REST mice, high levels of REST were associated with postnatal beta cell
apoptosis, which resulted in gradual beta cell loss and sustained hyperglycemia in adults. Moreover, adenoviral REST
transduction in INS-1E cells led to increased cell death under control conditions, and sensitized cells to death induced by
cytokines. Screening for REST target genes identified several anti-apoptotic genes bearing the binding motif RE-1 that were
downregulated upon REST expression in INS-1E cells, including Gjd2, Mapk8ip1, Irs2, Ptprn, and Cdk5r2. Decreased levels of
Cdk5r2 in beta cells of RIP-REST mice further confirmed that it is controlled by REST, in vivo. Using siRNA-mediated knock-
down in INS-1E cells, we showed that Cdk5r2 protects beta cells against cytokines and palmitate-induced apoptosis.
Together, these data document that a set of REST target genes, including Cdk5r2, is important for beta cell survival.
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Introduction
Type 1 (T1D) and type 2 (T2D) diabetes are characterized by an
absolute or relative insulin deficiency, respectively. In both diseases,
loss of functional beta cell mass occurs through beta cell apoptosis
[1,2]. While the triggering events and the nature of the molecular
effectors leading to diabetes-associated apoptosis are still disputed,
several critical regulators of beta cell survival have been identified
(Reviewed in [3]). Importantly, the search for intrinsic pro-survival
factors has identified several key proteins, including insulin receptor
substrate 2 (IRS2) [4,5], the anti-apoptotic members of the BCL2
family: BCL2 [6,7] and BCL2L1 (also called BCLXL) [8],
MAPK8IP1 (also called islet brain 1) [9], protein tyrosine
phosphatase, receptor type, N (PTPRN, also called islet cell antigen
512) [10], AKT1 (also called AKT/PKB) [11].
Our incomplete knowledge of the mechanisms responsible for
the unusual susceptibility of beta cells to metabolic stress and
inflammation, imposes that specific positive regulators of beta cell
mass are identified. To better understand what is a beta cell, and
to attempt improving it under pathological situations [12], we
initiated a search for new beta cell-specific genes. Generating
transgenic mice expressing the transcriptional repressor REST
specifically in beta cells (RIP-REST mice) allowed us to identify
the function of a wide group of uncharacterized genes that
contains the REST binding motif, called Repressor Element 1
(RE-1) [13]. REST is a zinc finger transcription factor which
blocks the expression of neuroendocrine traits in all cell types, but
neurons and beta cells. Indeed, REST is commonly absent in
mature insulin-producing cells and neurons [14–16], but sup-
presses elsewhere the expression of a large set of RE-1-containing
genes, thereby ensuring that their expression is specific to
neuroendocrine cell types. Upon ectopic REST expression in the
RIP-REST transgenic mice, REST target genes were specifically
silenced in beta cells. The resulting phenotype showed that, in vivo,
RE-1-containing genes are crucial for proper beta cell function
[13]. The identification that several bona fide REST target genes
code for proteins that are key to exocytosis further substantiated
our observations [13]. Here, we report the characterization of a
novel line of RIP-REST founder mice which demonstrates that
RE-1-containing genes are also essential to beta cell survival.
These mice featured diabetes as a consequence of a gradual but
extensive loss of beta cells through apoptosis. In vitro experiments
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with INS-1E cells transduced with REST-expressing adenoviral
vectors led to the identification of several new REST target genes,
with previous identified role in cell survival, including Irs2, Ptprn,
and CDK5 activator subunit 2 (Cdk5r2, also called p39). siRNA-
specific down-regulation of Cdk5r2 increased the susceptibility of
INS-1E cells to major beta cell death effectors cytokines and
palmitate, indicating that this activator of CDK5 has an anti-
apoptotic activity in beta cells.
Results
Diabetic RIP-REST mice feature hyperglycemia and
altered insulin secretion
We previously reported the characterization of a glucose-
intolerant mouse line (referred to as RIP-REST) featuring defects
in insulin secretion as well as decreased insulin production, without
detectable transgene expression in hypothalamus [13]. Mice from
a novel line (referred to as diabetic RIP-REST) showed frank
diabetes independently of the gender. These mice featured a
glycemia of 23.662.6 mmol/l at 4 weeks of age, which increased
at 3 month-old up to 33 mmol/l, resulting in lethality after few
months. Wild type littermates had a basal glucose level of
9.261 mmol/l (Fig. 1A). To assess insulin secretion, the pancreas
of 4–5 month-old transgenic and wild type animals were perfused
in situ. Infusion of 8.0 and 16.0 mmol/l glucose led to a typical
biphasic response of insulin secretion in control mice. In contrast,
the secretion of the hormone in response to glucose was barely
detectable in the diabetic animals (Fig. 1B). The addition of
1 nmol/l GLIP-1 to 8.0 mmol/l glucose largely potentiated
insulin release from wild type mice, and to a much lesser extent
also in diabetic RIP-REST mice (Fig. 1B).
Altered insulin secretion of diabetic mice results from
massive loss of beta cells
Immunofluorescent labeling of glucagon and insulin in pancreas
of 6 month-old mice showed that wild type islets featured, as
expected, numerous central beta cells and lower number of alpha
cells at the periphery (Fig. 2A left panel). In contrast, those of
diabetic RIP-REST mice had much fewer beta cells, and displayed
glucagon-positive cells scattered throughout the islets (Fig. 2A
middle panel). Strikingly, only a small fraction of the surviving beta
cells expressed the REST transgene (Fig. 2A right panel). When the
same staining was performed on pancreas of 7 day-old mice (P7), a
significant number of insulin positive cells was observed in the
diabetic mice (Fig. 2B middle panel), of which most expressed the
REST transgene (Fig. 2B right panel). However, and in contrast to
controls (Fig. 2B left panel), alpha cells were already distributed
throughout the islets of diabetic mice (Fig. 2B middle panel). To
further characterize the time course of the beta cell loss occurring
in diabetic mice, we quantified beta- and alpha-cell mass in P2, P7
and adult animals. Compared to wild type mice, we observed a
gradual decrease in the beta cell fraction, which was 30 (p,0.05),
45 (p,0.05), and 90% (p,0.001) in P2, P7 and adult diabetic
mice, respectively. In contrast, the alpha-cell mass was statistically
similar to that of controls at all ages (Fig. 2C). Confocal
microscopy also revealed the infrequent occurrence of double
insulin- and glucagon-positive cells in adult diabetic RIP-REST
mice, which was not observed in wild type mice (Fig. 2D).
REST expression is associated with beta cell loss due to
apoptosis
To investigate the postnatal beta cell loss in diabetic RIP-REST
mice, we first examined beta cell proliferation by PCNA
immunostaining in P2 pancreas. The same proportion of beta
cells was labeled for this marker of cell proliferation in wild type
(4.9%61.1; n = 1598), and transgenic mice (6.2%60.26; n = 833)
(Fig. 3A). We next assessed beta cell apoptosis using TUNEL
experiments. Whereas no apoptotic beta cell was observed in wild
type mice, we detected several in islets of diabetic RIP-REST mice
at P2 (Fig. 3B). We did not quantify the proportion of apoptosis, in
vivo, because apoptotic cells are rapidly cleared by the immune
system [17,18]. However, we assessed apoptosis in INS-1E cells
transduced with REST- and GFP-expressing adenoviruses and
observed that REST expression per se led to an increase in cell
death under normal conditions and in a dose-dependent manner
(Fig. 3C). The susceptibility of these cells to undergo apoptosis was
also increased when cell death was triggered by cytokines (Fig. 3C).
Together with the quantifications made in Fig. 2C, these
observations suggest that diabetes of transgenic mice was
accounted for by postnatal apoptosis of beta cells.
The levels of REST expression inversely correlate with
pancreatic insulin content in RIP-REST transgenic mice
We analyzed the mice of a third transgenic line (referred to as
RIP-REST 5), which was obtained after the pronuclear injection
of the RIP-REST transgene. As the other RIP-REST mice, these
mice also featured glucose intolerance, as observed by IPGTT
(Fig. 4A). Measurement of pancreatic insulin content in each three
transgenic line indicated that RIP-REST 5 mice featured a mild
30% decrease in insulin content, whereas RIP-REST mice had a
50% decrease, and diabetic RIP-REST mice a drastic 85%
reduction, as compared to wild type mice (Fig. 4B). qPCR analysis
of islet mRNA indicated that the expression of the REST transgene
was six-fold higher in RIP-REST than in RIP-REST 5 mice
(Fig. 4C). Diabetic RIP-REST mice could not be investigated by
qPCR because of the low number of residual islets. Therefore,
REST protein abundance in the three mouse lines was evaluated
by semi-quantitative peroxydase REST immunostaining (Fig. 4D
upper panel). After image processing, quantification of the average
pixel intensity per nuclei revealed that REST abundance was
significantly higher in beta cells from diabetic RIP-REST than
from RIP-REST mice, itself being higher than in beta cells from
RIP-REST 5 mice (Fig. 4D lower panel). These data demonstrate
an inverse relationship between the levels of REST expression and
insulin production, and suggest that high levels of REST in beta
cells were sufficient to induce diabetes in transgenic mice.
RE-1 database screening identifies several RE-1-
containing genes involved in beta cell survival
We screened a RE-1 database (http://www.bioinformatics.
leeds.ac.uk/cgi-bin/RE1db/nrse.cgi) [19] to search for RE-1-
containing genes thought to be involved in neuroendocrine-cell
protection. We searched genes with anti-apoptotic properties and
a conserved RE-1 sequence. We identified 14 RE-1-containing
genes that may be involved in growth signals transduction
pathways (including members of the insulin-like growth factors
pathway, AKT1, and catenin isoforms), in transduction of
apoptosis/proliferation (including mitogen-activated protein ki-
nases) and in downstream mechanisms of mitogenesis (including
cyclins, cyclin-dependent kinase activators) (Fig. 5A).
We then used qPCR analysis to evaluate the expression of the
corresponding mRNAs upon REST expression in INS-1E cells.
These experiments showed that the majority of the selected
candidates were not transcriptionally regulated by REST (data not
shown). However, the expression of the genes coding for IRS2,
PTPRN, CDK5R2, neuregulin1 (NRG1), delta2 catenin
REST Target Genes and Beta Cell Survival
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(CTNND2) and apoptosis inhibitor 5 (API5) were significantly
reduced after expression of REST in INS-1E cells (Fig. 5B). While
IRS2 and PTPRN are known to have anti-apoptotic effects [4,10],
the latter four proteins were not, prior to our study. To verify
whether these genes were downregulated in vivo upon REST
expression, and could account for the apoptotic events occurring
in the diabetic RIP-REST mice, we analyzed islets of RIP-REST
mice. qPCR experiments showed that the expression levels of
several REST target genes, including Gjd2, Mapk8ib1, Ptprn and
Cdk5r2 were reduced (Fig 5C). In contrast, we did not see any
downregulation for Irs2, Nrg1 or Ctnnd2 in these transgenic mice
(Fig 5C). Decreased production of Cdk5r2 upon REST expression
was also confirmed at the protein level using INS–1E cells
transduced with Ad-REST and Ad-GFP as a control (Fig. 5D). We
further evaluated the possibility that beta cells from RIP-REST
mice were suffering from apoptosis, due to ER stress that may be
induced by enhanced levels of RIP-mediated protein translation.
However, we failed to detect any increase in the transcript levels of
the ER stress markers, Chop, Bip and splice Xbp-1 in the islets of
RIP-REST mice, compared to wild type animals (Fig. S1).
Specific siRNA silencing of Cdk5r2 increases INS-1E cells
susceptibility to cytokines
We then assessed the role of Cdk5r2, given that this protein was
not yet known to be involved in beta cell apoptosis. Out of three
siRNAs tested, we selected two specific rat Cdk5r2 siRNAs
(siCdk5r2#1 and siCdk5r2#2) which efficiently silenced the
target sequence, as judged by qPCR experiments conducted on
transfected INS-1E cells (data not shown). Transfection of these
siRNAs into INS-1E cells resulted in a 70% to 80% reduction of
Cdk5r2 protein level after 72 h (Fig. 6A). This change did not affect
the levels of Cdk5r1 (also called p35), another activator of CDK5
(data not shown). We then evaluated the effect of silencing Cdk5r2
Figure 1. Diabetic RIP-REST transgenic mice are hyperglycemic and show poor insulin secretion. A. Blood glucose levels were assessed at
different ages in male and female diabetic RIP-REST transgenic (dark diamonds; n = 7) and wild type mice (open diamonds; n = 5). Diabetic RIP-REST
mice feature hyperglycemia from weaning onward. Results are mean 6 SD. ***P,0.001 versus values of wild type mice. B. Diabetic RIP-REST mice
(black circles, n = 3) and wild type littermates (open squares, n = 4) were subjected to in situ pancreatic perfusion at 1.5 ml/min rate. After a 30-min
equilibration period at basal 1.4 mmol/l glucose, the pancreas was perfused sequentially at different glucose concentrations, first at 1.4 mmol/l for
20 min, next at 8.0 mmol/l for 20 min, then at 16.0 mmol/l for 20 min, followed by a 30-min stimulation at 8.0 mmol/l plus 1 nmol/l GLP-1, and finally
at 1.4 mmol/l for 15 min. Results are mean 6 SD.
doi:10.1371/journal.pone.0045844.g001
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expression on the capacity of INS-1E cells to survive to a cytotoxic
attack or palmitate incubation. To this end, 56 h after siRNA
transfection, INS-1E cells were treated during 24 h with a mix of
IL1-b, TNF-a and IFN-c. Cdk5r2 silencing per se had no effect on
INS-1E cells viability, as compared to non-transfected cells
(Fig. 6B). However, siCdk5r2#1 and siCdk5r2#2 transfection
increased the cytokine-induced apoptosis by 60% and 50%,
respectively, as compared to cells transfected with the control
siRNA (Fig. 6B). Western blotting performed with total proteins
from the same experiment confirmed that Cdk5r2 knock-down
aggravated the cytokine-induced apoptosis, as quantified with
increased cleavage of caspase-9 and 23, an early and late
apoptosis marker, respectively (Fig. 6C). Similarly, siCdk5r2#1
and siCdk5r2#2 transfections increased apoptosis induced by a
24 h treatment with palmitate (0.5 mM) by 60% and 40%,
respectively (Fig. 6D). These results indicate that Cdk5r2 contrib-
utes to protect beta cell against both cytokines and free fatty acid-
induced apoptosis.
Discussion
Recent bioinformatic studies on the distribution of RE-1
binding sites in the genome, combined with analysis of chromatin
occupancy mediated by REST, have revealed the existence of
several hundred putative REST target genes [19–24]. The caveat
of these large output studies is the lack of functional assessment of
the candidate genes. The generation of transgenic mice expressing
REST in beta cells represents a reliable model to identify the
importance of RE-1-containing genes in insulin-producing cells
[13]. Specifically, analysis of the glucose-intolerant RIP-REST
mice led to the identification of several REST target genes which
are key to exocytosis of insulin-containing granules [13]. We now
document a role for REST target genes in beta cell survival in a
RIP-REST mouse line which displayed diabetes, as a result of a
high level of REST expression, which was associated with a
massive loss of adult beta cells.
This massive loss is due to the down-regulation of multiple
REST target genes, whose number is likely to increase with REST
levels. Indeed, transcription factor abundance is an important
parameter influencing the activity of many, though not necessarily
all cognate DNA binding motifs [25]. Furthermore, sequence
variations in the RE-1 binding motif establish a hierarchy of
binding affinity for REST to its target genes, indicating that genes
bearing a weakly conserved RE-1 motif have a suboptimal binding
affinity for REST [26]. Thus, it is likely that more genes are down-
regulated in the diabetic than in the glucose-intolerant RIP-REST
transgenic mice, due to the higher expression of REST in the
former animals. Using RE-1 database screenings and our in vitro
model of REST gain of function, we further show that REST
expression triggers 1) beta cell death under normal conditions 2)
increased sensitivity to cytokines and palmitate 3) decreases the
Figure 2. REST expression is associated with a major loss of beta cell mass. A. Immunostaining for insulin (Ins, red) and glucagon (Glu, green)
reveals, when compared to wild type mice (WT, left panel), a major loss of insulin-positive cells, within a low number of disorganized islets in pancreas
of adult diabetic RIP-REST mice (middle panel). REST nuclear staining (green, right panel) indicates that only a few surviving beta cells still express
REST. Blue staining is the DAPI labeling of nuclei. Scale bar, 25 mm. B. Immunostaining for insulin (Ins, red) and glucagon (Glu, green) shows that, even
if disorganized when compared to islets from wild type animals (WT, left panel), islets from diabetic RIP-REST mice at postnatal day 7 (P7) show a
significant number of insulin-positive cells (middle panel). REST nuclear staining (green, right panel) indicates that a majority of beta cells express
REST. Blue staining is the DAPI labeling of nuclei. Scale bar, 50 mm. C. Quantification of beta-(Ins+ cells) and alpha- (Gluc+ cells) cell mass in P2, P7 and
adult diabetic RIP-REST (black bars, n = 3 each) and wild type mice (white bars, n = 3 each). A 30, 45 and 90% reduction in beta cell mass is observed in
P2, P7, and adult diabetic RIP-REST mice, respectively, when compared with corresponding mass of controls. Results are mean 6 SD. *P,0.05,
***P,0.001 versus values of wild type mice. D. Confocal analysis of insulin (Ins, red) and glucagon (Glu, green) immunofluorescence shows scarce
double insulin-and glucagon-expressing cells (arrows) in pancreatic sections of adult diabetic RIP-REST mice. Blue staining is the DAPI labeling of
nuclei. Scale bar, 25 mm.
doi:10.1371/journal.pone.0045844.g002
Figure 3. Beta cell loss in diabetic RIP-REST mice occurs
through apoptosis. A. Nuclear PCNA (green) and insulin (red) staining
show same level of proliferating beta cells (arrows) in both wild type
(WT, left panel) and diabetic RIP-REST mice (right panel) at P2. Blue
staining is the DAPI labeling of nuclei. Scale bar, 50 mm. B.
Representative images of nuclear TUNEL (green) and insulin (red)
staining showing apoptotic nuclei of beta cells in sections of P2 diabetic
RIP-REST mice. No apoptotic beta cells were detected in wild type
animals (not shown). Blue staining is the DAPI labeling of nuclei. Scale
bar, 25 mm. C. Quantification of apoptotic nuclei in non-infected INS-1E
cells (NI) and INS-1E cells transfected with a control (Ad-GFP) or REST-
expressing adenovirus (Ad-REST) at different multiplicity of infection
(MOI) as indicated, and treated 24 h with a mix of cytokines (black bars)
or not (white bars). Results are mean 6 SD of six independent
experiments. *P,0.05 versus respective controls in treated or untreated
conditions. # P,0.05 versus MOI 2 of Ad-REST infection.
doi:10.1371/journal.pone.0045844.g003
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expression of several genes coding for known effectors of beta cell
survival/proliferation.
REST expression does not impact beta cell proliferation at P2,
and our observations suggest that the major consequence of high
levels of REST expression is a gradual postnatal loss of beta cell
mass. In a separate study, using an inducible REST transgene
under the control of the Pdx1 promoter, we also observed
postnatal beta cell loss leading to hyperglycemia (unpublished
data). While the effect of REST expression on INS-1E cells
survival was modest in normal conditions, we suggest that the
expression of REST target genes is crucial during the postnatal
remodeling of primary islet cells [27].
Searching for RE-1-containing genes bearing pro-survival
activity, we identified MAPK8IP1 [9,28], GJD2 [29], IRS2 [4]
and PTPRN [10]. We further discovered that Cdk5r2 [30] is an
additional, hitherto disregarded RE-1-containing gene that is
essential for beta cell survival. CDK5R2, like CDK5R1, is a
neuron and beta cell-specific activator of the atypical kinase
CDK5. This kinase phosphorylates a large number of substrates,
involved in a variety of neuronal and non-neuronal functions
(reviewed in [31]). Conflicting reports have described the role of
Figure 4. Increasing REST levels in beta cells lead to worsened glucose homeostasis. A. Blood glucose levels in 6 month-old wild type
(open triangles; n = 8), RIP-REST 5 (gray triangles; n = 8) and RIP-REST males (dark triangles; n = 10) during an IPGTT. After a 14 h fasting, blood samples
were taken before (t = 0) and after (t = 15, 30, 60 and 120 min) intraperitoneal injection of glucose (2 g/kg). Results are mean 6 SD. *P,0.05,
**P,0.01. B. Insulin content in pancreas of 5 month-old RIP-REST 5 (light gray bar; n = 8), RIP-REST (dark gray bar; n = 6) and diabetic RIP-REST (black
bar; n = 6) transgenic mice reveal a 30, 50 and 85% reduction, respectively, when compared with wild type mice (white bars, n = 6). Results are mean
6 SD. **P,0.01, ***P,0.001 versus values of wild type animals. C. Quantitative RT-PCR analysis of human REST mRNA levels in islets of 5 month-old
WT (white bar; n = 5), RIP-REST 5 (light gray bar; n = 6) and RIP-REST (dark gray bar; n = 6) mice. REST mRNA levels are six-fold higher in RIP-REST than
in RIP-REST 5 animals. Results are mean6 SD. **P,0.01 versus values of wild type animals. D. REST transgene abundance in islets from P2 RIP-REST 5,
RIP-REST and diabetic RIP-REST mice. Upper panel shows representative images of REST protein levels revealed using specific antibodies against REST
and AEC staining of peroxydase activity (nuclear black dots). Parallel immunostaining of insulin (red) and the merge shows colocalization of the two
signals. Scale bar, 25 mm. Lower panel shows the quantification of the corresponding average pixel intensity per nuclei for each group. *P,0.05
versus the two other groups.
doi:10.1371/journal.pone.0045844.g004
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CDK5 and its activators on insulin secretion. Whereas inhibition
of CDK5R1 activity was reported to promote insulin secretion
[32], the association of CDK5 to CDK5R2, but not CDK5R1,
has also been shown to induce insulin release [33]. The role of
CDK5 in neuronal survival is also a matter of debate.
Deregulation of CDK5 activity by p25 has been involved in
numerous neurodegenerative diseases [34,35], while Cdk5-loss-of-
function studies have revealed its pro-survival function in neurons
under normal [36–39] or stress conditions [36,37,40,41]. Similar-
ly, it is not clear whether CDK5 plays a prosurvival activity or not
in pancreatic beta cells. While its inhibition promoted PDX-1
nuclear localization and increased beta cell survival in response to
glucotoxicity [42], a recent publication showed that decreased
levels of CDK5 triggered apoptosis via loss of activation of focal
adhesion kinase and decreased PI3K/AKT signaling [43]. So far,
however, the role of CDK5R2 in beta cell survival has not been
explored. In the latter study, the authors proposed that CDK5R1
may be the activator form of CDK5 that is mediating the
prosurvival activity, neglecting the role of CDK5R2. Here, we
show that Cdk5r2 belongs to the cluster of RE-1-containing genes,
and therefore that it is crucial and specific to neurons and
pancreatic beta cells. Moreover, even though the silencing of
Cdk5r2 is not inducing beta cell death under normal conditions, we
provide evidence that its knock-down by two distinct siRNAs leads
to enhanced sensitivity of INS-1E cells exposed to pro-inflamma-
tory cytokines or palmitate, two mediators of beta cell apoptosis in
T1D and T2D, respectively [44].
In summary, the present findings extend our previous observa-
tions that ectopic expression of REST in beta cells allows for novel
insights into the specific traits that make a beta cell what it is [12].
Our work further demonstrates the need for healthy beta cells to
express the whole set of RE-1-containing genes. Specifically, we
show here that high chronic levels of REST in beta cells leads to
diabetes, due to prolonged repression ofmultipleREST-target genes
known to contribute to beta cell survival. We further identify a
hitherto neglected anti-apoptotic player, CDK5R2, which we show
to be essential for beta cell survival under conditions that trigger
apoptosis. Given the large number of estimated REST targets, it is
anticipated that several other genes, which remain to be identified
and validated, may play an important role in beta cell life and
function under the native conditions of lack of REST expression.
Materials and Methods
Transgenic mice
Transgenic mice specifically expressing REST in beta cells were
obtained by pronuclear injection of C57Bl6/J zygotes as
previously described [13]. Our institutional review committee for
animal experiments approved all the procedures for mice care,
surgery and euthanasia.
Pancreas perfusion and insulin secretion
Mice were anesthetized i.p with 100 mg/kg b:w sodium
pentothal, and prepared for pancreas perfusion as previously
described [45]. The pancreas was perfused at 1.5 ml/min at 37uC
with modified Krebs-Ringer HEPES buffer supplemented with the
indicated concentrations of glucose. The pancreatic effluent of the
first 30 min of perfusion with basal glucose (1.4 mmol/l) was not
collected. After this equilibration period, the effluent was collected
in 1-min fractions from a catheter placed in the portal vein. The
insulin content of each fraction was determined by radioimmu-
noassay.
Immunohistochemistry and confocal microscopy
Pancreas were fixed in 4% (w/v) paraformaldehyde, equilibrat-
ed overnight in 15% (w/v) sucrose, embedded in 15% sucrose-
15% (w/v) gelatin and quickly frozen in methylbutane/liquid
nitrogen. Cryosections were permeabilized for 20 min in 0.1%
Triton X-100, then blocked in 1.5% BSA in PBS for 30 min, and
incubated overnight at 4uC with either polyclonal rabbit
antibodies against human REST [46], glucagon (Dako, Baar,
Switzerland, 1/500), proliferating cell nuclear antigen (PCNA,
Dako, 1/200) or polyclonal guinea-pig antibodies against insulin
(Zymed Lab. Inc., San Francisco, USA, 1/500). Primary
antibodies were detected using appropriate fluorescein or rhoda-
mine-conjugated antibodies. A supplementary antigen-retrieval
treatment was required for anti-PCNA, which consisted of boiling
the slides in citrate buffer (10 mM Na-citrate, pH 6) for 10 min
before incubation with the blocking solution. Semi-quantitative
immunodetection of REST was performed using secondary
antibodies coupled to horseradish peroxidase from the rabbit
Vectastain ABC kit, using 3-amino-9-ethylcarbazole (AEC) as
substrate, according to the manufacturer’s instructions (Vector
Lab. Inc., Burlingame, CA, USA). Sections were viewed on either
a Leica DM5500 fluorescence microscope or a Leica SP2 upright
confocal microscope (Leica, Nidau, Switzerland). TUNEL labeling
was performed using the in situ cell death detection kit, according
to the manufacturer’s instructions (Roche Diagnostics, Rotkreuz,
Switzerland).
Image processing and cell mass quantification
For semi-quantitative assessment of REST abundance in beta
cells of transgenic mice, images have been processed as follow
using the ImageJ software: images were first converted to a 32 bit
format and subjected to background substraction. A binary image
was then created from a duplicated cropped region of interest (i.e
Figure 5. Identification of RE-1-containing genes potentially involved in beta cell survival. A. Alignment of identified RE-1 sequences in
human (hum) or murine (mus) genes with the consensus RE-1. Left alignment identifies members of the insulin-like growth factor transduction
pathway: Igfbp7: insulin-like growth factor binding protein 7; IRS: insulin receptor substrate; Akt3: PKB gamma; CTNND2: delta2 catenin; Ctnnb1: beta
catenin; MAPK10: JNK3; MAP4K3: MEK kinase kinase 3. Upper right alignment identifies members of the cyclin-related family of mitogenic factors:
Cdk5r2: cyclin-dependent kinase 5 regulatory subunit 2; CKS2: CDC28 protein kinase regulatory subunit 2; CNNG1: cyclin G1; Cnnm2: cyclin M2. Lower
right alignment identifies Api5: apoptosis inhibitor 5 and Nrg1: neuregulin1. B. Quantitative RT-PCR analysis of mRNA levels from control INS-1E cells
(white bars) and INS-1E cells infected with GFP-expressing adenovirus (gray bars) or REST-expressing adenovirus (black bars). Ptprn: protein tyrosine
phosphatase, receptor type, N; Irs2: insulin receptor substrate2; Cdk5r2: cyclin-dependent kinase 5 regulatory subunit 2; Nrg1: neuregulin1; Ctnnd2:
delta2 catenin; Api5: apoptosis inhibitor 5. Results are mean6 SD of six independent experiments. *P,0.05, **P,0.01, ***P,0.001 versus INS-1E cells
transduced with GFP. C. Quantitative RT-PCR analysis of mRNA levels from islets of WT (white bars) (n = 5) and RIP-REST (black bars) (n = 5) mice. Gjd2:
Connexin36; Mapk8ip1: Ib1; Cdk5r2: cyclin-dependent kinase 5 regulatory subunit 2; Ptprn: protein tyrosine phosphatase, receptor type, N; Irs2: insulin
receptor substrate2; Nrg1: neuregulin1; Ctnnd2: delta2 catenin. Results are mean 6 s.e.m. **P,0.01 versus values of wild type animals. D. Left panel,
immunoblotting of total proteins from non infected (NI) and infected (Ad-GFP, Ad-REST) INS-1E cells showing decreased protein levels of Cdk5r2
upon REST expression. The right panel shows the corresponding quantifications of REST protein levels in INS-1E cells after infection. Data are mean6
SEM of 4 independent experiments. **P,0.01, ***P,0.001 versus the respective Ad-GFP-infected and NI conditions.
doi:10.1371/journal.pone.0045844.g005
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an islet) by applying the MaxEntropy thresholding method. After
application of the ‘‘open’’ binary operation, particles were
detected fixing the minimum size at 100. The average pixel
intensity of nuclei (i.e, identified particles), was then measured
from the original cropped image and values obtained from at least
10 islets from three animals for each group were subjected to
statistical analyses.
For cell mass quantification, the relative area occupied by the
different types of islet cells were measured on 16 sections taken
throughout the entire pancreas and separated by at least 200 mm
(adult animals), or 150 mm (newborn animals). Islet cells and total
pancreas areas were measured using an ACECAD Professional
graphic tablet connected to a Quantimet Leica 5001 (Leica,
Cambridge Ltd, England) programmed for semiautomatic mea-
surement of areas.
Glucose tolerance test
Male mice of 12–16 weeks were fasted for 15 h before blood
samples were collected from the tail vein at 0 (fasting blood
sample), 15, 30 and 120 min after an intraperitoneal injection of
glucose (2 g/kg of body weight as a 20% solution). Blood glucose
levels were measured with a Glucometer (Bayer AG Health Care,
Switzerland).
Cell line and mouse islet isolation
The rat insulinoma cell line INS-1E was maintained in RPMI
1640 medium, as previously described [13]. For infection
experiments, INS-1E cells were seeded in 12-well plates and
cultured for 48 h before infection with adenoviruses as previously
described [46], with a multiplicity of infection of 2 or 5. Islets of
Langerhans of adult C57BL/6 male mice, weighing 25–30 g, were
isolated and cultured as previously described [13].
RNA isolation and real time RT-PCR
RNA isolation was performed as previously described [47].
Quantitative RT-PCR (qPCR) was performed using the SYBR
Premix Ex Taq PCR Kit TaKaRa (Axon Lab, Switzerland) in a
Lightcycler (Roche Diagnostics GmbH, Mannheim, Germany), as
previously described [47]. cDNAs were amplified using specific
primers (Table S1).
Apoptosis assay
Apoptosis was determined by scoring cells displaying picnotic
nuclei stained with the DNA-binding dyes Hoechst 33342 (10 mg/
ml; Molecular probes, Eugene, Oregon, USA), as visualized under
an inverted fluorescence microscope. A minimum of 500 cells were
counted in each experimental condition and viability was
evaluated by two independent observers, one of them unaware
of sample identity.
Western blotting
Western blots were performed as previously described [47].
Specific protein levels were revealed with polyclonal rabbit
antibodies against Cdk5r2, cleaved caspase-3 and cleaved
Figure 6. CDK5R2 protects beta cells against cytokines and
palmitate. A. Left panel, immunoblotting of total proteins from INS-1E
cells, 72 h after transfection with a negative siRNA (siNeg) or siRNAs
against Cdk5r2 (siCdk5r2#1 and siCdk5r2#2). Right panel, quantifica-
tion of the corresponding Cdk5r2 protein levels. Results are mean 6
SEM of three independent experiments. **P,0.01 versus values of
siNeg-transduced INS-1E cells. B. Quantification of apoptotic nuclei in
non-transfected INS-1E cells (NT) and INS-1E cells transfected with a
negative siRNA (siNeg) or with siRNAs against Cdk5r2 (siCdk5r2#1 and
siCdk5r2#2), treated 24 h with a mix of cytokines (black bars) or not
(white bars). Results are mean 6 SEM of six independent experiments.
**P,0.01 versus controls. C. Immunoblotting of total proteins from INS-
1E cells transfected with a negative siRNA (siNeg) or siRNAs against
Cdk5r2 (siCdk5r2#1 and siCdk5r2#2), treated 24 h with a mix of
cytokines (Cyt) or not (Ctrl). The cleavage of caspase-9 and 23, induced
by cytokines, is higher in siCdk5r2- than in siNeg-treated cells. D.
Quantification of apoptotic nuclei in non-transfected INS-1E cells (NT)
and INS-1E cells transfected with a negative siRNA (siNeg) or siRNAs
against Cdk5r2 (siCdk5r2#1 and siCdk5r2#2), exposed 15 h to control
medium (white bars) or palmitate (black bars). Results are mean 6 SEM
of six independent experiments. **P,0.01 versus controls.
doi:10.1371/journal.pone.0045844.g006
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caspase-9 (Cell Signaling Technology, Danvers, MA, USA).
Monoclonal antibodies against a-tubulin (Sigma-Aldrich, St-Louis,
MO, USA) were used to normalize the signals.
siRNA design and cell transfection
Specific siRNAs against rat Cdk5r2 were selected using the
siRNA Target Finder (Ambion, Austin, TX, USA). The silencing
efficiency of each construct was checked at the transcript level
using target genes fused to a luciferase reporter gene, as previously
described [13]. Two efficient siRNAs, siCdk5r2#1 (59-GCCAGC-
GUCCACCGGUCCCUU-39) and siCdk5r2#2 (59-GCCACC-
GUCGCUAUUACCGUU-39), and the negative siRNA(59AG-
GUAGUGUAAUCGCCUUGUU-39) were synthesized from
Microsynth (Balgach, Switzerland). INS-1E cells were seeded in
12-well plates and incubated overnight in antibiotic-free medium.
Negative or siRNA duplexes (60 pmol/ml) targeting Cdk5r2 were
mixed with Lipofectamine2000 reagent according to the manu-
facturer’s instructions (Invitrogen, Basel, Switzerland). siRNA-
lipofectamine complexes were added to the cells and incubated for
56 h. Cells were then exposed for 24 h to either a mixture of rat
IL-1b (0.5 ng/ml), mouse TNFa (1 ng/ml) and rat IFNc (10 ng/
ml) (R&D Systems, Minneapolis, MN, USA) [48] or to palmitate
(sodium salt; Sigma-Aldrich, St-Louis, MO, USA). Palmitate was
dissolved in 90% ethanol, heated to 60uC and diluted at a final
concentration of 0.4 mM in RPMI 1640 with 1% BSA and 1%
fetal calf serum) [49].
Statistical analysis
Data were expressed as mean 6 SD. Differences between
means were assessed using ANOVA followed by t-tests with
Bonferroni correction for multiple comparisons. Statistical signif-
icance was defined at a value of P,0.05 (*), P,0.01 (**) and
P,0.001 (***).
Supporting Information
Figure S1 ER-stress markers are not upregulated in
islets of transgenic RIP-REST mice. qPCR experiments on
islets from 5 month-old animals show identical levels of the
transcript of ER-stress markers in islets of RIP-REST mice. White
bars are wild type mice and black bars, RIP-REST mice.
(TIF)
Table S1 Specific primers for real time RT-PCR.
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